Larvol Delta - A-phase-3-randomised-doubleblind-placebocontrolled-clinical-trial-evaluation-of-the-efficacy-and-safety-of-a-SARSCoV2-recombinant-spike-RBD-protein-vaccine-in-adults-ABDALA3-study

Abdala (CIGB-66) - Center for Genetic Engineering and Biotechnology

http://www.ncbi.nlm.nih.gov/pubmed/37192953

May 17, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next